Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001804
Filing Date
2024-11-08
Accepted
2024-11-07 17:42:42
Documents
71
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q qnrx-20240930x10q.htm   iXBRL 10-Q 1073799
2 EX-31.1 qnrx-20240930xex31d1.htm EX-31.1 12006
3 EX-31.2 qnrx-20240930xex31d2.htm EX-31.2 11988
4 EX-32.1 qnrx-20240930xex32d1.htm EX-32.1 5829
5 EX-32.2 qnrx-20240930xex32d2.htm EX-32.2 5817
  Complete submission text file 0001410578-24-001804.txt   4974783

Data Files

Seq Description Document Type Size
6 EX-101.SCH qnrx-20240930.xsd EX-101.SCH 45989
7 EX-101.CAL qnrx-20240930_cal.xml EX-101.CAL 29721
8 EX-101.DEF qnrx-20240930_def.xml EX-101.DEF 178516
9 EX-101.LAB qnrx-20240930_lab.xml EX-101.LAB 364119
10 EX-101.PRE qnrx-20240930_pre.xml EX-101.PRE 278427
74 EXTRACTED XBRL INSTANCE DOCUMENT qnrx-20240930x10q_htm.xml XML 635643
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 10-Q | Act: 34 | File No.: 001-37846 | Film No.: 241437335
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)